AbbVie subsidiaries

Forest Laboratories, Inc. (NYSE: FRX) is a U.S.-based pharmaceutical company with a long track record of building partnerships and developing and marketing products that make a positive difference in people's lives. In addition to its well-established franchises in therapeutic areas of the central nervous and cardiovascular systems, Forest's current pipeline includes product candidates in all stages of development and across a wide range of therapeutic areas. The Company is headquartered in New York, NY.

Zeltiq (pronounced Zel ′teek) Aesthetics, founded in 2005, is a science-based medical device company dedicated to the development of non-invasive procedures for the reduction of unwanted fat tissue. The Zeltiq approach utilizes a patented method called Cryolipolysis™ (the use of precisely controlled cooling to remove fat) that is designed to target only fat cells and not harm the skin or other tissue. The Zeltiq device is cleared by the FDA in the Unites States for various applications related to skin cooling during dermatologic treatments.

Allergan Medical develops and manufactures breast aesthetics, dermal fillers, and other medical aesthetic products. The company offers saline and silicone filled surgically implantable breast implants; hyaluronic acid and collagen based dermal fillers; breast reconstruction tissue expanders; and facial reconstructive surgery and obesity intervention products under Juv derm, Zyplast, NATRELLE, and LAP-BAND brand names. The company also provides laparoscopic gastric surgery based products. It develops and markets Contigen, a collagen product used for the treatment of intrinsic sphincter deficiency caused urinary incontinence. It also owns and operates www.lookingyourbest.com, a Website that provides breast implants and facial cosmetic surgery based information and surgeons referral services. The company was formerly known as Inamed Corporation. The company was incorporated in 1974 and is based in Santa Barbara, California. Allergan Medical operates as a subsidiary of Allergan plc.

Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.

Aptalis Pharma US, Inc. markets pharmaceutical products and services for the treatment of gastrointestinal diseases and disorders. It offers pancrelipase capsules, ursodiol tablets, porfimer sodium for injections, shake mixes, calorie boosters, clearance devices, and multivitamin supplements. The company also provides products for active ulcerative proctitis, liver diseases, pancreatic diseases, cystic fibrosis, shwachman-diamond syndrome, chronic obstructive pulmonary disease, HIV/AIDS, and cancer. Aptalis Pharma US, Inc. was formerly known as Axcan Scandipharm, Inc. and changed its name to Axcan Pharma US, Inc. in December 1999. The company was founded in 1991 and is based in Birmingham, Alabama. As of August 3, 1999, Aptalis Pharma US, Inc. operates as a subsidiary of Allergan plc.

Warner Chilcott is a leading mid-size specialty pharmaceutical company focused on developing, manufacturing and marketing and selling branded prescription pharmaceutical products in womenâ€:tm:s healthcare and dermatology in the United States. We have established strong franchises in these two areas through our precision marketing techniques and specialty sales forces of over 400 representatives. We believe that our proven product development capabilities, coupled with our ability to execute acquisitions and in-licensing transactions and develop partnerships, will enable us to sustain and grow these franchises. Warner Chilcott is proud to boast sales over $800 MM and one of the largest sales forces devoted to womenâ€:tm:s healthcare and dermatology.

FRX Churchill Holdings, Inc. operates as a subsidiary of Allergan plc.

MAP Pharmaceuticals, Inc., a development stage company, focuses on developing novel inhalation therapies for respiratory and systemic diseases. It has various proprietary product candidates in clinical development, including Unit Dose Budesonide for pediatric asthma in children from six months to eight years of age and MAP0004 for migraine. The company's product portfolio also includes MAP0005 for the treatment of adolescent and adult asthma, and chronic obstructive pulmonary disease; and MAP0001 for the treatment of Type 1 and Type 2 diabetes via pulmonary delivery using its Tempo inhaler. MAP Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Mountain View, California.

Eurand N.V. (Eurand) is a holding company. The Company is a specialty pharmaceutical company that develops, manufactures and commercializes pharmaceutical and biopharmaceutical products. The Company is commercializing a portfolio of products for cystic fibrosis (CF) and gastrointestinal (GI) patients in the United States. As of December 31, 2009, it had two late-stage product candidates, EUR-1073 (beclomethasone) and EUR-1025 (ondansetron) in development in its own portfolio, as well as a number of other products in development with collaboration partners, including EUR-1000, which is partnered with GlaxoSmithKline (GSK). It has manufacturing and research facilities in the United States, Italy and France.

Abbvie Stemcentrx LLC is primarily engaged in performing noncommercial research into and dissemination of, information for public health, education, or general welfare. Establishments included here operate primarily on funds from endowments, contributions, and grants.

Forest Pharmaceuticals, Inc. manufactures, distributes, and sells prescription products in the United States and Puerto Rico. It offers pharmaceuticals for central nervous system, gastrointestinal, respiratory, cardiovascular, and hospital/anti-infective problems. The company offers its products in the form of tablets, capsules, and solutions. It supplies its products to pharmacies, healthcare facilities, and physicians, as well as through their mobile sales force. The company was founded in 1954 and is headquartered in St. Louis, Missouri with facilities in Ireland and Ohio. It has manufacturing and packaging plants in New York, Ohio, and Missouri. Forest Pharmaceuticals, Inc. operates as a subsidiary of Allergan plc.

Envy Medical is a biotechnology company providing dermatology and medical aesthetics solutions.